SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-15-000442
Filing Date
2015-02-17
Accepted
2015-02-17 16:20:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO SCHEDULE 13G sc13ga109543kin_12312014.htm SC 13G/A 133699
2 JOINT FILING AGREEMENT ex991to13ga109543kin_123114.htm EX-99.1 14554
  Complete submission text file 0000921895-15-000442.txt   149659
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Subject) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87768 | Film No.: 15622813
SIC: 2834 Pharmaceutical Preparations

Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-448-6534
EcoR1 Capital, LLC (Filed by) CIK: 0001587114 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A